Good genes: Researchers break down DNA of world’s largest mammals to discover how whales defy the cancer odds

Good genes: Researchers break down DNA of world’s largest mammals to discover how whales defy the cancer odds

May 9, 2019

  • Whales, which live longer than most mammals on the planet and have a much higher percentage of body fat, should be more likely to develop cancer. Yet their cancer rates are remarkably low. This phenomenon, known as Peto’s Paradox, is investigated in a new study and may provide tantalizing clues for addressing the disease in humans.

     Above: Image of Salt, an adult female humpback whale, taken by the Center for Coastal Studies under NOAA research permit 16325.


    Download Photo
  • Carlo Maley is senior co-author of the new study. He is a researcher in the Biodesign Virginia G. Piper Center for Personalized Diagnostics, professor at ASU's School of Life Sciences and director of the new Arizona Cancer Evolution Center.


    Download Photo
  • An illustration of Peto’s Paradox. The solid red line indicates a relationship between cancer rate and (body mass)*(lifespan), and the dashed red line represents an approximation of the expected cancer rate. The solid blue line represents the observation that there is no relationship between cancer risk and (body mass)*(lifespan). For instance, cancer risk, which is 11–25% in the human population, is not vastly different between mice and humans. In contrast, cancer risk was estimated to be 5% in elephants. Cancer rates in whales are not known, but these models predict that 100% of the largest whales should have cancer by age 90, which is an unlikely scenario. Metastatic cancer was found in a duck-billed dinosaur fossil. While adult body mass is approximately the same for the dinosaur and the elephant, duck-billed dinosaurs are thought to have had a shorter lifespan. This suggests the trade-offs between reproduction and growth and cancer defense mechanisms left these dinosaurs more susceptible to cancer than elephants. Figure is modified from Tollis, Boddy and Maley (2017)

     

     


    Download Photo

May 9, 2019

Scientists know that age and weight are risk factors in the development of cancer. That should mean that whales, which include some of the largest and longest-lived animals on Earth, have an outsized risk of developing cancer.

But they don’t. Instead, they are less likely to develop or die of this enigmatic disease. The same is true of elephants and dinosaurs’ living relatives, birds. Marc Tollis, an assistant professor in the School of Informatics, Computing, and Cyber Systems at Northern Arizona University, wants to know why.

Tollis led a team of scientists from Arizona State University, the University of Groningen in the Netherlands, the Center for Coastal Studies in Massachusetts and nine other institutions worldwide to study potential cancer suppression mechanisms in cetaceans, the mammalian group that includes whales, dolphins and porpoises. Their findings, which picked apart the genome of the humpback whale, as well as the genomes of nine other cetaceans, in order to determine how their cancer defenses are so effective, were published today in Molecular Biology and Evolution.

The study is the first major contribution from the newly formed Arizona Cancer Evolution Center or ACE, directed by Carlo Maley under an $8.5 million award from the National Cancer Institute. Maley, an evolutionary biologist, is a researcher at ASU’s Biodesign Virginia G. Piper Center for Personalized Diagnostics and professor in the School of Life Sciences. He is a senior co-author of the new study.

The study found that nature has beaten cancer in countless ways across the tree of life, Tollis said, and researchers can use that information to help find potential new targets for preventing cancer in humans, like using the whale version of a protein that can stop cell proliferation to develop drugs that shrink tumors in humans.

“Our goal is not only to get nature to inform us about better cancer therapies, but to give the public a new perspective of cancer,” Tollis said. “The fact that whales and elephants evolved to beat cancer, and that dinosaurs suffered from it as well, suggests that cancer has been a selective pressure across many millions of years of evolution, and it has always been with us. Our hope is that this may change people’s relationship with the disease, which can be painful and personal. It also helps provide even better appreciation for biodiversity. In our current sixth mass extinction, we need all the reasons for conservation that we can get.”

Why whales?

At its most basic, cancer occurs when body cells divide and mutate. Cell division is normal in living creatures, as are body cell, or somatic, mutations. Most of the time, somatic mutations are either harmless or the body is able to fix those mutations. When it doesn’t, that can lead to cancer.

Beyond that foundation, cancer gets much more complicated. For all of the research being done on all types of cancer and all types of organisms, there are still more questions than answers. However, age and body size are well-known risk factors in people. Tollis said one explanation for this is that cancer risk overall is a function of the number of cell divisions that occur over the lifetime of an organism.

“This is driven by somatic evolution—genetic changes that occur when body cells copy their genomes, divide and produce daughter cells,” he said. “The longer you live, the more cell divisions you have and the higher chance that a cancer-causing mutation will occur in the genome of the descendent cells. Similarly, larger individuals are made of more cells, which also increases the chance of cancer-causing mutations.”

Knowing this, it’s worth looking at whether whales, which live longer than most mammals on the planet and have a much higher percentage of body fat, are more likely to develop cancer. They aren’t. This phenomenon, known as Peto’s Paradox, is what Tollis and his team studied. How do whales defy these well-known risk factors? In earlier research, ASU’s Carlo Maley investigated alternate mechanisms responsible for cancer suppression in elephants.

Methods and conclusions

The team worked under a federal research permit to obtain skin samples from an adult female humpback whale off the coast of Massachusetts. This whale, named Salt, is well-known to researchers and whale watchers alike. She was cataloged by the Center for Coastal Studies in the mid-1970s and selected for this study because her life history is among the most well-documented of any individual humpback whale. The team sequenced and assembled Salt’s genome, which requires extracting DNA from skin tissue, fractioning it into smaller bits and put through a DNA sequencer that produces almost 2 billion short sequences. Then they put those sequences back together into a genome assembly that spans about 2.7 billion base pairs. (By contrast, the human genome is about 3.1 billion base pairs long.) They also sequenced RNA, which helps in the process of finding the precise coordinates where genes lie in the genome.

The team then compared the humpback whale genome to those of other mammals including other ocean giants like the blue whale, fin whale, bowhead whale and sperm whale. They expected to see a lot of differences, but also a few similarities, particularly with the parts of the genome that perform important functions. They also looked for parts of the genome that had evolved to help whales adapt to their environment.

What they found was that some parts of the whale genome have evolved faster than in other mammals. These parts of the whale genome contain genes that control the cell cycle, cell proliferation and DNA repair, which are essential for normal cell function. In human cancers, many of these genes are mutated. The whale genome also evolved many duplications in tumor suppressor genes.

“Nature is showing us that these changes to cancer genes are compatible with life. The next questions are, which of these changes is preventing cancer, and can we translate those discoveries into preventing cancer in humans?” said Carlo Maley, a cancer evolutionary biologist from ASU’s Biodesign Institute and one of the two senior authors, who started this project in 2011 with Per Palsbøll, a marine mammal conservation geneticist from the Groningen Institute for Evolutionary Life Sciences at University of Groningen, in collaboration with Jooke Robbins from the Center for Coastal Studies.

“This suggests that whales are unique among mammals in that in order to evolve their gigantic sizes, these important ‘housekeeping’ genes, that are evolutionarily conserved and normally prevent cancer, had to keep up in order to maintain the species’ fitness,” Tollis said. “We also found that despite these cancer-related parts of whale genomes evolving faster than other mammals, on average whales have accumulated far fewer DNA mutations in their genomes over time compared to other mammals, which suggests they have slower mutation rates.”

This slow rate of change may also limit whales’ exposure to cancer-causing somatic mutations.

This study builds on research that the ASU team has done finding lower rates of cancer in elephants, another mammal that is large and can live a long time but doesn’t have much in common genetically with whales. Both species arrived at the same result—cancer suppression—through different mechanisms. The same is likely true of extinct giant dinosaurs; although scientists have found evidence of cancer in dinosaur fossils, this group of organisms includes the largest animals ever to walk the earth and thus they probably had efficient cancer suppression as well.

Next steps for Tollis and his team will be to better understand the cancer suppression phenotype using experiments with whale cell lines, which will provide important functional validation of the team’s genomic results. That will be the first step in generating whale-derived human cancer drugs. They also are looking at other animals, such as bats, tortoises and crocodilians, to see how these varied long-lived species suppress cancer. The humpback whale genome also will serve as the basis for studies by other team members on whale mutation rates and other adaptations taking advantage of a collection of the 9,000-plus DNA samples collected from free-ranging humpback whales curated by Palsbøll’s team.

This research is supported by the Arizona Cancer Evolution Center, which is funded through a five-year grant from the National Institutes of Health, with additional funding by the University of Groningen.

Contact:
Heidi Toth (928) 523-8737 heidi.toth@nau.edu

Richard Harth (480) 727-0378 richard.harth@asu.edu

 

The Biodesign Institute addresses today’s critical global challenges in health care, sustainability and security by developing nature-inspired solutions for global impact.

Arizona Cancer Evolution (ACE) Center has been established through the generous support of the National Cancer Institute, which selected Arizona State University to join its Cancer Systems Biology Consortium. ACE’s mission is to advance fundamental understanding of cancer and its clinical management through the development and application of evolutionary and ecological models to cancer biology. ASU participants in the interdisciplinary consortium include Biodesign Institute, Hugh Downs School of Human Communication, Beyond Center and the Department of Biomedical Informatics. International participants include the University of Southern California; University of California, Santa Barbara; University of Zurich; Barts Cancer Center at the Queen Mary University of London; the Institute of Cancer Research; the Huntsman cancer Institute at the University of Utah; Stanford University; and North Carolina State University.

Research at the Arizona Cancer Evolution Center or ACE is supported by the National Cancer Institute of the National Institutes of Health under Award Number U54CA217376. The content provided here is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

 

Written by: Heidi Toth